Earnings
YMTX
17.66
-1.34%
-0.24
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2019-12-31
25.01M
44.46M
--
--
--
--
0.00
--
--
--
1.40M
--
70.87M
13.03M
--
--
--
--
--
--
828.00K
13.85M
84.72M
--
2.28M
0.00
--
--
--
--
--
8.02M
--
--
--
--
10.30M
0.00
--
--
--
12.05M
12.05M
22.35M
52.00K
398.98M
-336.66M
--
--
--
62.38M
62.38M
84.72M
FY 2018-12-31
28.81M
89.57M
--
--
--
--
0.00
--
--
--
2.48M
0.00
120.86M
14.45M
--
--
--
--
--
--
828.00K
15.28M
136.14M
--
1.88M
0.00
--
--
--
--
--
6.72M
--
--
--
0.00
8.60M
0.00
--
--
--
13.20M
13.20M
21.80M
51.00K
391.82M
-277.54M
--
--
--
114.34M
114.34M
136.14M
FY 2017-12-31
29.72M
44.74M
--
--
--
--
0.00
--
--
--
1.38M
294.00K
76.13M
896.00K
--
--
--
--
--
--
1.69M
2.58M
78.72M
--
2.10M
0.00
--
--
--
--
--
6.68M
--
--
--
1.11M
9.88M
0.00
--
--
--
25.00K
25.00K
9.91M
35.00K
285.58M
-216.81M
--
--
--
68.81M
68.81M
78.72M
FY 2016-12-31
18.61M
66.90M
--
668.00K
--
--
0.00
--
--
--
4.06M
--
90.24M
541.00K
--
--
--
--
--
--
362.00K
903.00K
91.14M
--
2.02M
0.00
--
--
--
--
--
4.33M
--
--
--
2.40M
8.75M
0.00
--
--
--
930.00K
930.00K
9.68M
26.00K
238.90M
-157.45M
--
--
--
81.46M
81.46M
91.14M
FY 2015-12-31
13.84M
--
--
918.00K
--
--
0.00
--
--
--
180.00K
--
14.94M
566.00K
--
--
--
--
--
--
3.18M
3.75M
18.69M
--
3.33M
0.00
--
--
--
--
--
2.25M
--
--
--
4.26M
9.84M
110.00K
--
--
--
4.55M
4.66M
14.50M
1000.00
12.12M
-120.22M
--
--
--
4.19M
4.19M
18.69M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out YMTX latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Yumanity Therapeutics Inc recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.